Introgen Therapeutics, Inc. (INGN)
Article Abstract:
The operations and management of Intogen Therapeutics Inc of Austin, TX, are discussed in detail by president and CEO David G. Nance. Gene therapy products for cancer treatment is the company's major focus.
Publisher: Wall Street Transcript Corporation
Publication Name: The Wall Street Transcript
Subject: Business
ISSN: 0043-0102
Year: 2001
Nance, David G., Introgen Therapeutics Inc.
Publication Name: The Wall Street Transcript
Subject: Business
ISSN: 0043-0102
Year: 2001
User Contributions:
Comment about this article or add new information about this topic:
Restoragen, Inc
Article Abstract:
The operations and management of Resoragen Inc of Lincoln, NE, are discussed in detail by chairman and CEO Thomas R. Coolidge. The company provides peptide hormone therapies for a wide variety of diseases.
Publisher: Wall Street Transcript Corporation
Publication Name: The Wall Street Transcript
Subject: Business
ISSN: 0043-0102
Year: 2001
Coolidge, Thomas R., Restoragen Inc.
Publication Name: The Wall Street Transcript
Subject: Business
ISSN: 0043-0102
Year: 2001
User Contributions:
Comment about this article or add new information about this topic:
Subjects list: United States, Management, Biological products industry, Biological products, Interview, Company Profile
Similar abstracts:
- Abstracts: Collateral Therapeutics,Inc. (CLTX). Chiron Corporation (CHIR). A.P. Pharma, Inc. (APPA)
- Abstracts: Gentiva Health Services, Inc. (GTIV). CV Therapeutics, Inc. (CVTX)
- Abstracts: Orphan Medical, Inc. (ORPH). InterMune Pharmaceuticals, Inc. (TMM)
- Abstracts: Vertex Interactive, Inc. (VETX). Made2Manage Systems, Inc. (MTMS)
- Abstracts: Axcess Inc. (AXSI). Paradyne Networks, Inc. (PDYN)
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.